Michel A Horisberger

Title: Michel A Horisberger: Innovator in Immunoassays and Antiviral Proteins

Introduction

Michel A Horisberger is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of immunology, particularly in the development of immunoassays and antiviral proteins. With a total of 3 patents, his work has had a profound impact on medical diagnostics and therapeutic applications.

Latest Patents

Horisberger's latest patents focus on the purification and application of proteins induced in human cells by interferon .alpha. or .beta. His inventions include processes for the preparation and purification of these proteins, as well as the development of monoclonal antibodies specific to them. These antibodies are crucial for the qualitative and quantitative determination of the proteins, and they are incorporated into test kits and pharmaceutical preparations. The proteins he has worked on show antiviral properties attributed to interferons, making them valuable indicators of cellular response to interferon therapy.

Career Highlights

Throughout his career, Michel A Horisberger has worked with prominent companies such as Ciba-Geigy Corporation and Novartis AG. His experience in these organizations has allowed him to advance his research and contribute to significant innovations in the field of immunology.

Collaborations

Horisberger has collaborated with esteemed colleagues, including Jean Content and Heinz-Kurt Hochkeppel. These partnerships have further enriched his research and development efforts in the field.

Conclusion

Michel A Horisberger's contributions to immunology and antiviral research highlight his role as a leading inventor in the field. His innovative patents and collaborations continue to influence medical diagnostics and therapeutic strategies.